Importance of tumor load in the sentinel node in melanoma: clinical dilemmas (Q33611835)

28 July 2017

1 reference

title

Importance of tumor load in the sentinel node in melanoma: clinical dilemmas (English)

1 reference

Alexander M. M. Eggermont

28 July 2017

author

series ordinal

object named as

Alexander M M Eggermont

1 reference

28 July 2017

Cornelis Verhoef

1 reference

28 July 2017

author name string

Alexander C J van Akkooi

series ordinal

1 reference

28 July 2017

language of work or name

English

0 references

publication date

22 June 2010

1 reference

Nature Reviews Clinical Oncology

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

446-454

1 reference

What is a sentinel node and what is a false-negative sentinel node?

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Melanoma incidence has risen in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Technical details of intraoperative lymphatic mapping for early stage melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Metastatic pathways and time courses in the orderly progression of cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The orderly progression of melanoma nodal metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel-node biopsy or nodal observation in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Results of sentinel lymph node biopsy in patients with thin melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Importance of sentinel lymph node biopsy in patients with thin melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Pathologic examination of sentinel lymph nodes from melanoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The development of optimal pathological assessment of sentinel lymph nodes for melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph nodes in malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Patterns of early recurrence after sentinel lymph node biopsy for melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph node biopsy for melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Melanoma recurrence patterns after negative sentinel lymphadenectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Actual False-Negative Rate Prompts the Routine Use of Ultrasound Scan Before and After Sentinel Node Biopsy in Melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Reliability of sentinel lymph node biopsy for staging melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The detection and significance of melanoma micrometastases in sentinel nodes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Detection of melanoma micrometastases in sentinel nodes - the cons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The rationale for sentinel-node biopsy in primary melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel node biopsy: facts to clear the alleged clouds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Is sentinel-node biopsy superior to nodal observation in melanoma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph nodes in melanoma patients: evaluating the evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The current status of evaluation and treatment of high-risk cutaneous melanoma: therapeutic breakthroughs remain elusive

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prognostic false-positivity of the sentinel node in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prediction of nonsentinel lymph node status in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Micrometastases or isolated tumor cells and the outcome of breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.100

Epidemiology of invasive cutaneous melanoma

31 March 2020

1 reference

12 December 2020

The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

1 reference

12 December 2020

Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma

1 reference

12 December 2020

Cloud over sentinel node biopsy: unlikely survival benefit in melanoma

1 reference

12 December 2020

Regional recurrence after negative sentinel lymph node biopsy for melanoma

1 reference

12 December 2020

10.1038/NRCLINONC.2010.100

Identifiers

DOI

1 reference

28 July 2017

1 reference